An Isolated-Heart Study Linked Angiotensin Responses to Endocannabinoid Signaling Without Testing Marijuana

A 2021 rat-heart experiment found evidence that endogenous cannabinoid signaling modulated angiotensin II responses. The intervention and model did not establish the cardiovascular effects of using marijuana or taking THC.

The preparation isolated a mechanistic question

Researchers used perfused rat hearts and confirmed cardiac CB1 receptor expression. Angiotensin infusions changed coronary flow and contractile responses, with a more pronounced response on first administration. The isolated preparation does not reproduce every regulatory process in a living person.

Pathway interventions supplied comparisons

The investigators tested 2-AG, an experimental cannabinoid agonist, a CB1 blocker and an inhibitor relevant to endocannabinoid production. The pattern supported modulation through endocannabinoid release and receptor activation. It did not directly quantify a clinical cannabis effect.

Different response levels should remain separate

Coronary flow, contractility and metabolic-demand interpretations are related but distinct. The proposed pathway helps explain results within the model. It cannot establish that stimulating the same system with a different compound, route or dose has a beneficial cardiovascular outcome in patients.

Interpreting the evidence

This study is relevant to cannabinoid-system physiology, not a marijuana treatment recommendation. It does not show that cannabis improves coronary flow, protects the heart or produces the same response as an endogenous signal. Model, intervention and measured endpoint must remain explicit.

Related reading: interpreting cannabis tolerance claims.

Research reference

Miklós Z; Wafa D; Nádasy GL; Tóth ZE; Besztercei B; Dörnyei G; Laska Z; Benyó Z; Ivanics T; Hunyady L; Szekeres M (2021). Angiotensin II-Induced Cardiac Effects Are Modulated by Endocannabinoid-Mediated CB1 Receptor Activation. Cells. doi:10.3390/cells10040724.

This analysis draws on the supplied abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

A 2021 pilot study reported strong initial antinociceptive responses to THC and cannabinolic acid, followed by decreasing responses over subsequent days. The evidence concerns adult male mice and experimental mechanical and thermal tests. The study evaluated two nociceptive domains Mechanical and thermal responses were assessed after systemic intraperitoneal administration. Those…

Spread the love

Read Article: A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A 2001 mouse study found different opioid- and cannabinoid-receptor protein patterns across midbrain and spinal cord after short-term THC–morphine treatment. A statement about total receptor change would obscure those tissue-specific comparisons. The comparison included separate treatment groups Investigators assessed THC, morphine and their combination using Western blot measurements. Opioid-receptor protein…

Spread the love

Read Article: Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

A 2003 study found that selected kinase inhibitors reversed THC antinociceptive tolerance while others did not. One higher-dose intervention reduced THC's acute antinociceptive effect, illustrating a different outcome from reversing tolerance. The panel included useful negatives The study tested interventions directed at several kinases. Some did not affect tolerance under…

Spread the love

Read Article: A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us